Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza.


Journal

Critical reviews in food science and nutrition
ISSN: 1549-7852
Titre abrégé: Crit Rev Food Sci Nutr
Pays: United States
ID NLM: 8914818

Informations de publication

Date de publication:
2019
Historique:
pubmed: 11 5 2018
medline: 30 10 2019
entrez: 11 5 2018
Statut: ppublish

Résumé

Salvia miltiorrhiza (Danshen in Chinese), is a well-known traditional Chinese medicinal plant, which is used as not only human medicine but also health-promotion food. Danshen has been extensively used for the treatment of various cardiovascular and cerebrovascular diseases. As a major group of bioactive constituents from S. miltiorrhiza, water-soluble phenolic acids such as salvianolic acid B possessed good bioactivities including antioxidant, anti-inflammatory, anti-cancer and other health-promoting activities. It is of significance to improve the production of phenolic acids by modern biotechnology approaches to meet the increasing market demand. Significant progresses have been made in understanding the biosynthetic pathway and regulation mechanism of phenolic acids in S.miltiorrhiza, which will facilitate the process of targeted metabolic engineering or synthetic biology. Furthermore, multiple biotechnology methods such as in vitro culture, elicitation, hairy roots, endophytic fungi and bioreactors have been also used to obtain pharmaceutically active phenolic acids from S. miltiorrhiza. In this review, recent advances in bioactivities, biosynthetic pathway and biotechnological production of phenolic acid ingredients were summarized and future prospective was also discussed.

Identifiants

pubmed: 29746788
doi: 10.1080/10408398.2018.1474170
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antineoplastic Agents 0
Antioxidants 0
Antiviral Agents 0
Drugs, Chinese Herbal 0
Hydroxybenzoates 0
Phytochemicals 0
dan-shen root extract 1693AM5SBN
phenolic acid I3P9R8317T

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

953-964

Auteurs

Min Shi (M)

a Laboratory of Medicinal Plant Biotechnology, College of pharmacy, Zhejiang Chinese Medical University , Hangzhou , Zhejiang , People's Republic of China.

Fenfen Huang (F)

b Institute of Plant Biotechnology, Development Center of Plant Germplasm Resources, College of Life and Environment Sciences, Shanghai Normal University , Shanghai , People's Republic of China.

Changping Deng (C)

b Institute of Plant Biotechnology, Development Center of Plant Germplasm Resources, College of Life and Environment Sciences, Shanghai Normal University , Shanghai , People's Republic of China.

Yao Wang (Y)

b Institute of Plant Biotechnology, Development Center of Plant Germplasm Resources, College of Life and Environment Sciences, Shanghai Normal University , Shanghai , People's Republic of China.

Guoyin Kai (G)

a Laboratory of Medicinal Plant Biotechnology, College of pharmacy, Zhejiang Chinese Medical University , Hangzhou , Zhejiang , People's Republic of China.
b Institute of Plant Biotechnology, Development Center of Plant Germplasm Resources, College of Life and Environment Sciences, Shanghai Normal University , Shanghai , People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH